Sanofi

News

scientifically visualization of a coronavirus spike protein

EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine

The EMA has kicked off a rolling review of a COVID-19 vaccine from Sanofi and GlaxoSmithKline, which started a 35,000-patient phase 3 trial in May.

News

Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive

Sanofi has just significantly increased its investment in mRNA vaccine development, earmarking €400 million ($475 million) a year in R&D funding to an effort that it hopes will deliver

News

AZ, Sanofi prep filings for one-shot RSV antibody after tria...

AstraZeneca and Sanofi now have the data they need in hand to press ahead with regulatory filings next year for nirsevimab, an antibody designed to prevent respiratory syncytial virus (RSV)

News

Libtayo gets a double with EU approvals in skin, lung cancer

Sanofi and Regeneron's checkpoint inhibitor Libtayo has tripled its approved uses in Europe, after getting the nod for the treatment of advanced basal cell carcinoma (BCC) and advanced non-

News

Talking vaccines: Industry’s role in protecting the Gavi generation

Sanofi and Translate take first mRNA flu vaccine into clinic

Sanofi and Translate Bio have started a first clinical trial of an mRNA-based seasonal flu vaccine, adding to the COVID-19 shot already in testing as part of their three-year old collaborat

News

After FDA rejection, EU says yes to Sanofi's Aubagio in kids...

Sanofi's Aubagio has become the first oral therapy approved for first-line use in children and adolescents with multiple sclerosis in the EU, a few days after the same indication was turned

EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine

Sanofi doubles down on mRNA jabs with €400m-a-year R&D drive

AZ, Sanofi prep filings for one-shot RSV antibody after tria...

Libtayo gets a double with EU approvals in skin, lung cancer

Sanofi and Translate take first mRNA flu vaccine into clinic

After FDA rejection, EU says yes to Sanofi's Aubagio in kids...

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Sanofi

Editor's Picks